Ignota Labs Acquires Kronos’s Clinical Pipeline

Contributed by: Business Wire

Logo

Tags

Research

Technology

Clinical Trials

Software

Biotechnology

Pharmaceutical

Health

Science

Oncology

Artificial Intelligence

health

More Like This

Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395

PR Newswire associated0

Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody

Calliditas announces filing with UK MHRA for Kinpeygo in IgA nephropathy

Vertex Announces Key Advancements Across Kidney Portfolio

Ichnos Glenmark Innovation (IGI) Presents First Clinical Data from Phase 1 Study of Trispecific TREAT™ Antibody, ISB 2001, Showing High Overall Response Rate (ORR) with Durable Responses and Favorable Safety Profile in Patients with Heavily Pretreated Multiple Myeloma

PR Newswire associated0

Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AI

Calliditas Presents Data from the NefIgArd Phase 3 trial at the 17th International Symposium on IgA Nephropathy (IIgANN) Tokyo 2023

Exscientia Acquires Full Rights to Potential Best-in-Class CDK7 Inhibitor Ahead of Phase 1 Dose Escalation Data Readout